Our earlier study found that TRIM32 was expressed at elevated levels in GC tissues and cell lines, which resulted in enhanced cell proliferation, migration, and invasion, as well as a poorer prognosis [13]. This evidence concerns the gene TRIM32 and gastric cancer.